# DrugGuard AI – Requirements Document

## GenAI-Powered Polypharmacy Risk Detection and Explanation System for Indian Healthcare

---

## 1. Problem Statement

Polypharmacy — the concurrent use of multiple medications — is a growing concern in India, particularly among elderly patients and individuals with chronic diseases such as diabetes, hypertension, and cardiovascular disorders.

### Current Challenges

Indian patients often:
- Consult multiple doctors independently
- Use over-the-counter medications
- Combine allopathic medicines with Ayurvedic/herbal supplements
- Lack centralized prescription monitoring

### Associated Risks

This increases the risk of:
- Drug–drug interactions (DDIs)
- Organ toxicity (liver/kidney overload)
- Cardiac risks such as QT prolongation
- Duplicate therapeutic mechanisms
- Adverse hospitalization events

Currently, most drug interaction tools are static lookup systems and do not provide holistic, patient-specific risk reasoning tailored to Indian healthcare realities.

**DrugGuard AI** aims to build a GenAI-powered system that detects, analyzes, and explains polypharmacy risks using interaction graphs and AI-driven reasoning.

---

## 2. Motivation

India's aging population and high burden of chronic disease are increasing medication complexity.

### Key Challenges

- Limited consultation time for doctors
- Lack of integrated EHR systems
- Minimal pharmacovigilance at outpatient level
- Rising self-medication trends

There is a need for an intelligent, explainable, and scalable system that assists clinicians and patients in identifying high-risk drug combinations before adverse events occur.

DrugGuard AI addresses this gap by combining graph-based risk modeling with generative AI explanations to enhance medication safety in India.

---

## 3. Application

### Deployment Scenarios

DrugGuard AI can be deployed in:
- Hospitals and outpatient clinics
- Community pharmacies
- Telemedicine platforms
- Elderly care management systems

### Real-World Use Case

A 72-year-old patient inputs:
- Age, gender
- Existing conditions (e.g., diabetes, hypertension)
- Current medications (e.g., Metformin, Amlodipine, Aspirin, Ibuprofen)

The system:
1. Builds a drug interaction graph
2. Detects interaction severity clusters
3. Calculates a polypharmacy risk score
4. Identifies organ burden risks
5. Generates AI-based clinical explanation
6. Suggests safer alternatives or consultation alerts

---

## 4. Proposed Method

DrugGuard AI integrates structured pharmacological data with generative AI reasoning across four core layers:

### A. Drug Interaction Graph Engine

- Each drug is represented as a node
- Drug–drug interactions are represented as weighted edges
- Edge weights correspond to severity (mild, moderate, severe)
- Graph analysis identifies high-risk clusters and dangerous triads
- Graph modeling will be implemented using NetworkX in Python

### B. Risk Scoring Algorithm

The system computes a composite **Polypharmacy Risk Score** based on:
- Interaction severity summation
- Age-based risk multiplier
- Organ toxicity overlap (liver/kidney load)
- Duplicate therapeutic class detection
- High-risk mechanism patterns (e.g., anticoagulant + NSAID)

Risk score categories:
- Low Risk
- Moderate Risk
- High Risk
- Critical Risk

### C. Pattern Detection Module

The system identifies:
- Cytochrome P450 metabolic overload
- QT-prolonging drug combinations
- Anticholinergic burden
- Triple-risk combinations linked to kidney injury
- Overlapping mechanism-of-action risks

This ensures deeper analysis beyond simple pairwise interaction lookup.

### D. Generative AI Explanation Layer

Structured risk outputs are passed to a Large Language Model (LLM) to generate:
- Personalized risk explanation
- Mechanism-based reasoning
- Severity justification
- Clear patient-friendly summary
- Clinical caution recommendations

This transforms technical pharmacological data into interpretable insights for clinicians and patients.

---

## 5. Datasets / Data Sources

The prototype will use publicly available datasets:
- DrugBank interaction dataset
- OpenFDA adverse event data
- WHO ATC drug classification database
- Public drug–drug interaction datasets
- Synthetic patient dataset for simulation

All datasets used will comply with open-source or publicly authorized access requirements.

---

## 6. Experiments and Validation

The system will be evaluated through:

### Interaction Detection Accuracy
- Comparing detected DDIs with known database interactions
- Precision and Recall metrics

### Risk Scoring Validation
- Testing against documented high-risk clinical combinations
- Sensitivity analysis of scoring model

### Explanation Quality
- Manual evaluation of LLM-generated explanations
- Clinical plausibility verification

### Simulation Testing
- Synthetic patient scenarios with known risk outcomes

---

## 7. Novelty and Scope to Scale

### Novelty

- Moves beyond static drug lookup systems to graph-based cluster analysis
- Integrates structured pharmacological modeling with GenAI reasoning
- Includes organ burden modeling for comprehensive risk detection
- Designed specifically for Indian polypharmacy patterns

### Scalability

DrugGuard AI can scale as:
- SaaS for clinics and pharmacies
- Integration into hospital EMR systems
- Mobile app for elderly care monitoring
- Real-time prescription validation tool

### Future Extensions

- Genomic risk integration
- Wearable device data integration
- Federated learning across hospitals
- Real-time pharmacovigilance dashboards

---

## 8. Expected Impact

- Reduction in preventable adverse drug events
- Improved medication safety for elderly patients
- Support for clinicians in high workload environments
- Strengthened pharmacovigilance ecosystem in India

DrugGuard AI aims to enhance safe prescribing practices using interpretable and scalable generative AI systems.

---

## Technical Requirements Summary

### Core Components
1. Drug Interaction Graph Engine (NetworkX)
2. Risk Scoring Algorithm
3. Pattern Detection Module
4. Generative AI Explanation Layer (LLM Integration)

### Technology Stack
- Python for backend processing
- NetworkX for graph modeling
- LLM API integration for explanations
- Database for drug interaction data

### Data Requirements
- Drug interaction databases
- Patient demographic data
- Clinical condition mappings
- Therapeutic class classifications

### Performance Requirements
- Real-time risk assessment (< 5 seconds)
- High accuracy in DDI detection (> 95%)
- Explainable and clinically valid outputs

---

**Document Version:** 1.0  
**Last Updated:** February 15, 2026
